the association between Ki67 and clinical features in patients with advanced EGFR-positive lung adenocarcinoma
Not Applicable
- Conditions
- 40 cases diagnosed advanced lung adenocarcinoma. The 20 cases were EGFR mutation positive and treated with EGFR inhibitors, and the other 20 cases are EGFR mutation negative and treated with chemotherapy and/or immunotherapy.
- Registration Number
- JPRN-UMIN000042886
- Lead Sponsor
- Tohoku Medical and Pharmaceutical University,Tohoku Medical and Pharmaceutical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients having an overlap cancer with activity Patients that an doctor judged to be inappropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We measure the staining intensity of Ki67 in EGFR-positive and EGFR-negative cases, and examine the effect with EFGR inhibitors and prognosis of according to the intensity of Ki67 in EGFR-positive cases.
- Secondary Outcome Measures
Name Time Method